These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21886851)

  • 1. The impact of a filariasis control program on Lihir Island, Papua New Guinea.
    Mitjà O; Paru R; Hays R; Griffin L; Laban N; Samson M; Bassat Q
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1286. PubMed ID: 21886851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011.
    Graves PM; Makita L; Susapu M; Brady MA; Melrose W; Capuano C; Zhang Z; Dapeng L; Ozaki M; Reeve D; Ichimori K; Kazadi WM; Michna F; Bockarie MJ; Kelly-Hope LA
    Parasit Vectors; 2013 Jan; 6():7. PubMed ID: 23311302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.
    Tisch DJ; Alexander ND; Kiniboro B; Dagoro H; Siba PM; Bockarie MJ; Alpers MP; Kazura JW
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1241. PubMed ID: 21765964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
    Richards FO; Eigege A; Miri ES; Kal A; Umaru J; Pam D; Rakers LJ; Sambo Y; Danboyi J; Ibrahim B; Adelamo SE; Ogah G; Goshit D; Oyenekan OK; Mathieu E; Withers PC; Saka YA; Jiya J; Hopkins DR
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1346. PubMed ID: 22022627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control.
    Njenga SM; Mwandawiro CS; Wamae CN; Mukoko DA; Omar AA; Shimada M; Bockarie MJ; Molyneux DH
    Parasit Vectors; 2011 May; 4():90. PubMed ID: 21612649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar.
    Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ
    Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
    Weil GJ; Kastens W; Susapu M; Laney SJ; Williams SA; King CL; Kazura JW; Bockarie MJ
    PLoS Negl Trop Dis; 2008; 2(12):e344. PubMed ID: 19065257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
    da Silva JSF; Braga C; Duarte FM; Oliveira P; Feitosa Luna C; Marcondes M; Araújo J; Grilis MR; de Souza Melo PFA; Brandão E; Rocha A
    Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass treatment to eliminate filariasis in Papua New Guinea.
    Bockarie MJ; Tisch DJ; Kastens W; Alexander ND; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
    N Engl J Med; 2002 Dec; 347(23):1841-8. PubMed ID: 12466508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
    Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology and control of lymphatic filariasis on Lihir Island, New Ireland Province.
    Hii J; Bockarie MJ; Flew S; Genton B; Tali A; Dagoro H; Waulas B; Samson M; Alpers MP
    P N G Med J; 2000; 43(3-4):188-95. PubMed ID: 11939300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
    Ojha CR; Joshi B; Kc KP; Dumre SP; Yogi KK; Bhatta B; Adhikari T; Crowley K; Marasini BR
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005788. PubMed ID: 28723904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
    Swaminathan S; Perumal V; Adinarayanan S; Kaliannagounder K; Rengachari R; Purushothaman J
    PLoS Negl Trop Dis; 2012; 6(11):e1926. PubMed ID: 23209865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
    Tavul L; Laman M; Howard C; Kotty B; Samuel A; Bjerum C; O'Brian K; Kumai S; Amuga M; Lorry L; Kerry Z; Kualawi M; Karl S; Makita L; John LN; Bieb S; Wangi J; Weil GJ; Goss CW; Tisch DJ; Pomat W; King CL; Robinson LJ
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010096. PubMed ID: 35139070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
    Modi A; Gamit S; Jesalpura BS; Kurien G; Kosambiya JK
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005476. PubMed ID: 28369129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
    Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
    Laman M; Tavul L; Karl S; Kotty B; Kerry Z; Kumai S; Samuel A; Lorry L; Timinao L; Howard SC; Makita L; John L; Bieb S; Wangi J; Albert JM; Payne M; Weil GJ; Tisch DJ; Bjerum CM; Robinson LJ; King CL
    Lancet Infect Dis; 2022 Aug; 22(8):1200-1209. PubMed ID: 35533701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.